Top 10 Blockbuster Biotech Drugs

Top 10 Biologics

Over the summer we took a look at the Top 15 Bestselling Drugs of 2008. Now we're turning our attention to the biotech industry's blockbusters. As traditional pharmaceuticals face an increasing threat from generics, many drug developers are turning their focus to biologics, which are much more resistant to pricing pressure. Here's a look at the current cream of the crop--the top 10 blockbuster biologics. Slideshow ⇒

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.